A trial study finds a malaria vaccine appears to cut infections by half in a one-year period.
SB Pharmaco, a unit of health care giant GlaxoSmithKline, pleaded guilty to charges it sold "adulterated" drugs made at a now-closed plant in Puerto Rico, federal regulators said Tuesday.
A Food and Drug Administration committee delivered a split verdict on the diabetes drug Avandia on Wednesday, with most members voting to leave it on the market but recommending different changes in how it's prescribed.
FDA officials will decide the ultimate fate of the diabetes drug Avandia. CNN's Dr. Sanjay Gupta reports.
A Food and Drug Administration committee delivered a split verdict on the diabetes drug Avandia on Wednesday, with most members voting to leave it on the market but recommending changes in how it's prescribed.
For at least a decade, anyone following the life sciences industry has noticed two naked truths.
The diabetes drug Avandia is linked with tens of thousands of heart attacks, and drugmaker GlaxoSmithKline knew of the risks for years but worked to keep them from the public, a Senate committee report released Saturday says.
The diabetes drug Avandia is linked with tens of thousands of heart attacks, and drugmaker GlaxoSmithKline knew of the risks for years but worked to keep them from the public, according to a Senate committee report released Saturday.
More than 1,100 people worldwide have died from swine flu since it emerged in Mexico and the U.S. in April, according to the latest figures from the World Health Organization.
Sales of the flu drug Relenza shot up 1,900 percent from a year ago as governments around the world stockpiled in preparation for a swine flu pandemic, drugmaker GlaxoSmithKline said Wednesday.
Australia starts vaccine trials for the H1N1 virus. SBS's Jenny Lavelle reports.
The first week of November has been brutal for the job market, with nearly 15,000 announced job cuts from a slew of companies across multiple industries.
Stock futures fluctuated early Friday after a key report on the U.S. labor market showed a bigger-than-expected job loss in March.
Britain plans to force pharmaceutical companies to share more information with regulators about clinical trials after an investigation recently concluded that GlaxoSmithKline PLC deliberately withheld information about an antidepressant
CNN's Charles Hodson talks with GlaxoSmithKline CEO Jean-Pierre Garnier about his company's recent drop in earnings.
Dr. Sanjay Gupta profiles man with no medical experience who invented a machine meant to cure cancer.
CNN's Elizabeth Cohen reports on Maryland families who were ordered to have their kids vaccinated or face prosecution.
CNN's Dr. Sanjay Gupta reports on a new strain of the common cold virus that has killed at least 10 people.
The market for treatment of human immunodeficiency virus, or HIV, is mutating as rapidly as the virus itself, and drug industry heavyweight GlaxoSmithKline could find its lead position in jeopardy.
America's 20 million-plus diabetics mean dollar signs for drug companies that sell a slew of new products, including a successful drug based on the saliva of a Gila monster, and a failed inhalation device that's been compared to a "bong."
Merck's cervical cancer vaccine Gardasil now faces direct competition from Glaxo's Cervarix, which was approved by European health authorities, said the vaccine's maker GlaxoSmithKline on Monday.
Stocks suffered a steep selloff Tuesday afternoon after a bold start with the Dow industrials falling nearly 150 points on more subprime mortgage woes and record-high oil prices.
CNNMoney: Bull run loses steamupdated: Tue Jul 31 2007 02:03:00
Early gains on Wall Street all but evaporated in Tuesday afternoon trading, as investors eyed new credit market developments and the latest corporate earnings.
GlaxoSmithKline is getting ready for a face-to-face with the FDA about its diabetes drug Avandia, which has been on the hot seat since a study blamed the drug for increasing the risk of heart attack.
The controversy surrounding GlaxoSmithKline's diabetes drug Avandia mounted Wednesday as a medical expert prepared to tell lawmakers the British drug maker threatened him with legal action when he first raised questions about the treatment's safety
GlaxoSmithKline PLC revealed Thursday that the U.S. Food and Drug Administration has declined to grant a priority review to its experimental cancer vaccine Cervarix
The recently published study results that link GlaxoSmithKline's blockbuster diabetes drug Avandia to heart attacks could shift market share to rivals Merck, Lilly and Amylin, despite questions surrounding the data, analysts say.
The British drugmaker GlaxoSmithKline is trying wean just a little more revenue from its top-selling blockbuster Advair, and its ability to do so depends on whether FDA experts believe the allergy drug merits a larger patient population.
GlaxoSmithKline is getting closer to launching its challenge against Merck's monopoly on cervical cancer vaccines.
The Food and Drug Administration approved GlaxoSmithKline's breast cancer drug Tykerb, the drug company said Tuesday.
The Food and Drug Administration is expected to approve a breast cancer treatment from GlaxoSmithKline on Tuesday, analysts say.
Worried about bird flu? If Sanofi has its way, America could soon be getting its first FDA-approved vaccine.
The FDA's decision to grant over-the-counter status to GlaxoSmithKline's weight loss drug Alli could have big implications on national health, but the drug is not a miracle cure, experts said.
The U.S. government awarded Novartis and GlaxoSmithKline contracts worth more than $100 million to develop vaccines to protect against the possibility of a bird flu pandemic, the drug companies said.
The biotech Amgen and the drugmaker GlaxoSmithKline announced similar results for experimental blood-clotting drugs and could find themselves locking horns in the near future.
Besides extra pounds, dieters also seem to carry a hefty independent streak. A survey finds that 70 percent of Americans who are trying to lose weight are following their own diet plans and have no interest in seeking a doctor's help.
Hey Big Pharma, listen up: this is NOT the time to be dropping the ball on a blockbuster.
Imagine this: a worldwide network of radio-tagged pharmaceuticals, weeding out the multi-billion dollar counterfeit drug market with a universal security system.
GlaxoSmithKline ranks no. 143 on FORTUNE's Global 500 this year, with $39.4 billion in revenues, up 5.5% from the previous year. The Brentford, Britain-based company was ranked no. 122 on the 2005 list. Its 2005 profits were $8.8 billion, up 8.1% from a year earlier. 2005 was a banner year for most Global 500 companies.
Fortune: Patently unfairupdated: Fri Sep 08 2006 06:01:00
On the top floor of a drab apartment building on the edge of New Delhi, Ram Meher, 35, is taking his AIDS medicine, as he has every day for the past three years. Meher is a struggling wheat and sug...
A British company announced this week that it has developed the first effective small-dose bird flu vaccine.
Vital protection against cervical cancer could soon be made available, not just from Merck but also from GlaxoSmithKline, providing life-saving potential for women while feeding a competitive atmosphere for the drug giants.
Tykerb, an experimental new drug from GlaxoSmithKline, significantly slowed the spread of breast cancer in clinical trials, according to study results released Saturday.
GlaxoSmithKline added the increased risk of suicide for young adults to its Paxil label this week, but the antidepressant is past its prime in terms of sales so it's unlikely to hurt the drugmaker.
The U.S. Department of Health and Human Services awarded $1 billion to drugmakers, including nearly $700 million to GlaxoSmithKline, Novartis and MedImmune, to help them develop a faster method of producing an influenza vaccine to better protect the nation against the possibility of a pandemic.
It's been quite a week for Sirna Therapeutics -- and it's still only Monday.
GlaxoSmithKline Plc has developed a new vaccine that could help prevent ear infections, a widespread problem for children, according to a study published in the British medical journal Lancet.
Paxil, a blockbuster antidepressant from GlaxoSmithKline, increases the risk of babies' heart defects in pregnant mothers, the Food and Drug Administration said Thursday.
Eliav Barr has popped the champagne. After a decade of development, his team at Merck has just finished presenting the clinical-trial results on the company's cervical cancer vaccine, Gardasil, to ...
GlaxoSmithKline chief executive officer Jean-Pierre Garnier said on Thursday that he intends to complete tests for a bird flu vaccine within the next two years.
GlaxoSmithKline will lose patent protection on a blockbuster migraine treatment in three years, but may have figured out how to protect sales by spinning off the drug as a new combination product, analysts say.
GlaxoSmithKline said it has taken steps to ramp up vaccine production to protect against avian flu following last week's meeting at the White House with President Bush, and other drug giants that participated in the meeting have offered to help.
GlaxoSmithKline has thrown its big pharma weight behind an experimental anti-cancer drug being tested by Human Genome Sciences.
With nearly 40 million people with AIDS worldwide, why aren't drug companies pouring everything they have into a cure for what some health workers call "the disease of mass destruction?"
You might expect GlaxoSmithKline CEO Jean-Pierre Garnier to be keeping a low profile. After all, top Glaxo antidepressants, including Paxil, are under fire for possible links to childhood suicides,...
Scientists have played down hopes that an AIDS vaccine could be developed within the next few years.
January 2000 still seemed like a blue-sky dream for most of the business world. But a dark cloud had already settled over the heads of Tachi Yamada and Jean-Pierre Garnier, two top executives at Sm...
From the looks of it, Pfizer is gearing up for a drug showdown. In late February the No. 1 drugmaker cut off two Canadian wholesalers that it said were supplying retailers who sell to Americans. It...
At least one pharmaceutical giant is sick and tired of Americans filling prescriptions in Canada, where drugs can sell for 30% to 70% less. On Jan. 21, GlaxoSmithKline, the maker of antidepressant ...
Coasting. That is the word that best describes the state of the world's largest corporations as they glided into 2001. Despite the bursting of the technology bubble and the deteriorating economic c...
The medical profession, like most businesses, has a food chain. And pharmacists, like any group of highly trained professionals, aren't crazy about being plankton.
While most of Wall Street slouches toward the holiday season, at least one part of the biz--mergers and acquisitions--has held up pretty darn well. Yes, the real blockbuster deals--Citi-Travelers, ...
An unexpected front has opened in the national war on AIDS: a battle for market share among the drugs used to combat the virus. Until recently the best-known "nucleoside reverse transcriptase inhib...
It seems that deals driven by big executive egos can also be undone by them. At least that's the best line so far on why pharmaceuticals giants Glaxo Wellcome and SmithKline Beecham called off thei...
The latest: Digital and Compaq, $9.6 billion; Glaxo and SmithKline, around $70 billion. The wave of mergers just keeps rolling, one blockbuster after another. Not that we should be surprised: We ma...
Uncertain. That's the best that can be said about the outlook for the world's biggest equity markets. MONEY chief investment strategist Michael Sivy warns that U.S. stocks may pull back as much as ...
From the outside, Glaxo Wellcome, the world's largest drugmaker, looks the picture of health. Pretax profits were up 11.6% last year, and profit margins were enviably robust. Glaxo also appears to ...
It's a blood-borne disease, transmitted through transfusions, sex, and shared needles. And it's a silent disease; people can go years before developing any symptoms.
IN AN ERA when new products are often vital to corporate success, why do so many companies botch their development? Harvard business school professors Steven Wheelwright and Kim Clark, who have stu...
EVEN IF YOU prefer backyard vacations and meat and potatoes, it pays to be cosmopolitan when you're investing. Just as any sound portfolio should spread risk across a number of industries, it makes...
NO AMERICAN INDUSTRY has ever defied the laws of economic gravity like pharmaceuticals. For the past 30 years the drugmakers of the FORTUNE 500 have enjoyed the fattest profits in big business. The...
On the strength of a single best-selling anti-ulcer drug, Zantac, Britain's Glaxo Holdings leaped in 10 years from 25th in pharmaceutical sales among the world's drugmakers to just behind $7.6 bill...
THE BULL MARKET in equities lives,'' says Robert Stovall, the fourth-place finisher in the 1987 Challenge. Stovall, 61, is president of Stovall/Twenty- First Advisers, a subsidiary of Twenty-First ...
© 2013 Cable News Network. Turner Broadcasting System, Inc. All Rights Reserved.
|